GlassScriptPhysician profile
Adrienne Greeney
NPI 1194345850
$2,244.42
in general payments reported to CMS, 2019-2025
16 companies · $376 in 2025
The $376 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $131 · 2022: $227 · 2023: $393 · 2024: $1,117 · 2025: $376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,448 · Travel and Lodging: $438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,447.69 |
| Travel and Lodging | $438.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $939.27 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| W. L. Gore & Associates, INC. | $575.67 | 2023-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Conformable Thoracic Endoprosthesis |
| Novartis Pharmaceuticals Corporation | $209.78 | 2021-2024 | |
| Pfizer INC. | $124.03 | 2022-2023 | |
| Amgen INC. | $72.56 | 2021-2023 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $65.14 | 2023-2025 | Eliquis |
| Janssen Pharmaceuticals, INC | $36.51 | 2023-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $35.96 | 2022-2023 | Lifevest |
| Cardiva Medical, INC. | $34.42 | 2021 | |
| Ossur Americas, INC. | $29.77 | 2024 | |
| Kerecis Limited | $24.57 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Tactile Systems Technology INC | $23.35 | 2024 | Flexitouch Plus, Entre Plus |
| Abiomed | $23.15 | 2024 | Impella |
| Astrazeneca Pharmaceuticals LP | $18.74 | 2024 | |
| Contego Medical, INC | $17.23 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $14.27 | 2023 | Manta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adrienne Greeney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.